Laboratory Corporation of... (LH)
Bid | 228.89 |
Market Cap | 19.16B |
Revenue (ttm) | 13.01B |
Net Income (ttm) | 746M |
EPS (ttm) | 8.84 |
PE Ratio (ttm) | 25.9 |
Forward PE | 15.56 |
Analyst | Buy |
Ask | 229.11 |
Volume | 455,368 |
Avg. Volume (20D) | 707,095 |
Open | 223.67 |
Previous Close | 221.46 |
Day's Range | 223.32 - 229.33 |
52-Week Range | 191.97 - 258.59 |
Beta | 0.97 |
About LH
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin ...
Analyst Forecast
According to 19 analyst ratings, the average rating for LH stock is "Buy." The 12-month stock price forecast is $267.5, which is an increase of 16.81% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription

2 months ago · seekingalpha.com
Labcorp Holdings: Focus On Core Strengths For Future Growth, Initiate At 'Hold'Labcorp Holdings Inc., a leader in life sciences and diagnostics, is efficiently managing its financials and focusing on core strengths for long-term growth, warranting a “Hold” rating. Competitive ad...